A61K 2039/876
Skin, melanoma
Official title: {Skin, melanoma}
A61K2039/876 (Skin, melanoma) appears on 107 US grants and 289 published applications in this corpus.
Search patents in A61K- Granted patents
- 107
- Published applications
- 289
- Assignees
- 179
- Inventors
- 685
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 2 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 2 |
| 2009 | 0 | 0 |
| 2010 | 1 | 4 |
| 2011 | 0 | 4 |
| 2012 | 0 | 0 |
| 2013 | 3 | 1 |
| 2014 | 1 | 5 |
| 2015 | 0 | 2 |
| 2016 | 4 | 3 |
| 2017 | 1 | 2 |
| 2018 | 1 | 5 |
| 2019 | 5 | 23 |
| 2020 | 2 | 24 |
| 2021 | 8 | 41 |
| 2022 | 11 | 51 |
| 2023 | 10 | 40 |
| 2024 | 18 | 33 |
| 2025 | 21 | 31 |
| 2026 | 18 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Oncolytic virus in combination with immune checkpoint inhibitor for treating tumors15 Sep 2026US 12,734,202 B2Joint Biosciences (Sh) Ltd.
- Intracellular delivery of biomolecules to modify immune response8 Sep 2026US 12,728,163 B2Stemcell Technologies Canada Inc.
- Compositions and methods for cancer therapy25 Aug 2026US 12,714,723 B2AIM ImmunoTech Inc.
- Application of Caerin 1.1/1.9 combined with anti-CD47 antibody in preparing drug for treating melanoma11 Aug 2026US 12,702,702 B2Wnl Biomed Tech Pty. Ltd.
- Edible plant exosome-like nanovectors for vaccination11 Aug 2026US 12,702,703 B2University of Louisville Research Foundation, Inc.
- A novel non-stoichiometric multi-element adjuvant (nsma) and composition thereof8 Oct 2026US 2026/0306624 A1Magvitae Innovations Inc
- Tumor Immunotherapy10 Sep 2026US 2026/0263573 A1Peking University Shenzhen Graduate School
- Neoantigen immunotherapies20 Aug 2026US 2026/0240970 A1Iogenetics, LLC
- Microbial consortium and uses thereof13 Aug 2026US 2026/0232742 A1Biomica Ltd.
- Compositions for inducing or rescuing glycolysis and methods of use thereof6 Aug 2026US 2026/0224680 A1Arizona Board of Regents on behalf of Arizona State University
Most cited
By later US patents
- Methods for reducing global chronic inflammation and the presence of melanoma51US 9,387,244 B2Mayo Foundation for Medical Education and Research · 2016
- Treatment of melanoma with a vaccine comprising irradiated autologous melanoma tumor cells conjugated to a hapten35US 5,290,551 AThomas Jefferson University · 1994
- Vaccines against melanoma26US 5,141,742 AOncogen · 1992
- Detection of individual T-cell reaction patterns against tumor-associated antigens (TAA) in tumor patients as a basis for the individual therapeutic vaccination of patients23US 8,349,558 B2Johannes Gutenberg-Universitat Mainz · 2013
- Cancer immunotherapy19US 9,308,253 B2The Johns Hopkins University · 2016